Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Medivolve Inc MEDVF

Medivolve Inc. is a Canadian healthcare technology company. The Company and its subsidiaries, Medivolve Pharmacy Inc. (doing business as Marbella Pharmacy) and Kedy Ying Jao D.O., a Medical Corporation, operate a distributed network of two retail patient-care locations in California, United States. It has two business units: Medivolve Pharmacy Division (MPD) and Medivolve Clinic Services Division (MCSD). MPD provides retail pharmacy and mail-order pharmacy services related to COVID-19, antibiotics, dermatology, family medicine, immunology, neurology, pain management, pediatrics, preventive medicine and psychiatry to patients in Southern California. MCSD provides licensed healthcare through a clinic in Brea, California, United States. MCSD is focused on developing a telehealth platform, which connects patients with physicians, and facilitates and manages the provision of virtual consultation, diagnosis, and treatment services in partnership with qualified health practitioners.


OTCPK:MEDVF - Post by User

Post by deepoil0808on Oct 09, 2021 11:18am
124 Views
Post# 33991855

Refund of $ 7.7 million USD from PCL ($300 milllion company)

Refund of $ 7.7 million USD from PCL ($300 milllion company)PCL Inc. trades on the Kosdaq Exchange in South Korea.

They have 10,090,000 shares outstanding trading at $ 31.70 per share USD (37.700 South Korea wons).

This gives them a market cap of:   $ 317,000,000  USD

This means that they can easily REFUND MEDV for its deposit of $ 7.7 million USD which was given for test kits which were not accepted by FDA.

This $ 7.7 million USD amount is closer to $ 10 million Canadian.

Stan Bharti paid off the promissory note that was due as they had borrowed the original funds to pay to PCL Inc. 

Stan Bhati has given MEDV a chance to recover these funds from PCL Inc.

We will see status of this claim in the next financials, hopefully it was recovered.

Here is the link to PCL Inc. 

https://www.bloomberg.com/quote/241820:KS
<< Previous
Bullboard Posts
Next >>